Biomedicine & Pharmacotherapy (Jul 2022)

Endogenous and exogenous hydrogen sulfide modulates urothelial bladder carcinoma development in human cell lines

  • Elisabetta Panza,
  • Ivana Bello,
  • Martina Smimmo,
  • Vincenzo Brancaleone,
  • Emma Mitidieri,
  • Mariarosaria Bucci,
  • Giuseppe Cirino,
  • Raffaella Sorrentino,
  • Roberta d′Emmanuele di Villa Bianca

Journal volume & issue
Vol. 151
p. 113137

Abstract

Read online

The role of H2S in urothelial carcinoma (UC) is still unclear. Here we have evaluated the expression of H2S producing enzymes as well as the effect of endogenous and exogenous H2S on human bladder UC cells. In human UC cells the expression of cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (3-MST); is significantly lower as compared to healthy cells. A modulatory role for the H2S pathway is supported by the finding that, the overexpression of CSE or CBS, but not 3-MST, inhibits cell proliferation and promotes apoptosis. A similar effect is obtained by using exogenous H2S. Diallyl trisulfide (DATS), which is a fully characterized H2S donor, inhibits the proliferation of UC cells in a time and concentration-dependent manner as well as promotes apoptosis. Moreover, DATS also induces autophagy, as determined by transcriptomic and western blot analysis. Finally, DATS inhibits mRNA expression levels of canonical markers of epithelial-mesenchymal transition by limiting migration and clonogenic ability of human UC cells in vitro. In conclusion, in urothelial carcinoma, there is an impairment of H2S pathway that involves CSE and CBS- derived hydrogen sulfide. Thus, targeting H2S signaling pathway in urothelial carcinoma could represent a novel therapeutic strategy.

Keywords